Board of Advisors
Our Board of Advisors, all industry leaders, have made a powerful statement by supporting Life Science Cares and our goal to end poverty in our community. Annually, our Advisors make a personal financial contribution to cover LSC’s administrative costs, allowing us to channel money raised from our event fundraisers, Corporate Membership Program, and from individuals to our partner organizations.
Our Board of Advisor members also choose to volunteer with their companies and recruit their colleagues to join in this collective effort. For more information on how to join our Board of Advisors please email [email protected]
SAN DIEGO BOARD OF ADVISORS
Chuck Baum
President, Founder and Head of Research & Development, and Board Member
Mirati Therapeutics
Chuck Baum
President, Founder and Head of Research & Development, and Board Member – Mirati TherapeuticsPresident and Chief Executive Officer
Chuck Baum, M.D., Ph.D.
Scott Bechtler-Levin
Head of Venture Insights – Redesign Health
Denise Bevers
President & CEO – Vetmab Bio
Greg Bisconti
Vice Chairman, National Life Science Practice Lead – Cushman & Wakefield
Tasia Blazevich
Managing Director – Deloitte
Sarah Boyce
President & CEO – Avidity Biosciences
Vika Brough
Senior Vice President of Finance – Prometheus Bioscience
Dan Burgess
Venture Partner – SV Health Investors
James Burns
Chief Executive Officer – Locana bio
Ousmane Caba
Partner – PwC
Jeremy Caldwell, PhD
President & Chief Executive Officer – Inception Therapeutics
Cris Calsada
Chief Financial Officer – Regulus Therapeutics
Carin Canale-Theakston
Chief Executive Officer – Evoke Canale
Travis Carter
President – Carter+Co
Joseph Castagnola
Managing Director, Private Wealth Advisor – Morgan Stanley
Jacob Chacko
CEO – ORIC PharmaceuticalsCEO
ORIC Pharmaceuticals
Isan Chen M.D.
President & CEO – MBrace Therapeutics, Inc.
Tom Coll
Partner – Cooley
Dee Dee DeMan
Chairman & CEO – Bench International
Karen Deschaine
Partner – Wilson Sonsini Goodrich & Rosati
Michael Dudley
President and Chief Executive Officer – QPEX BIOPHARMA
David Duenas
EVP of Consulting/ Life Sciences and Strategic Accounts Practice Leader
Hub Insurance Services Inc.
David Duenas
EVP of Consulting/ Life Sciences and Strategic Accounts Practice Leader – Hub Insurance Services Inc.
Laure Escoubet
Senior Vice President, Head of Research – Light Horse Therapeutics
Dan Estes, Ph.D
General Partner – Frazier Life Sciences
Daniel Faga
Chief Executive Officer – AnaptysBio
Kevin Finney
Chairman & CEO – Autobahn Therapeutics, Inc
Robert Gaan
Chief Investor Relations Officer – Christopher Weil & Company, Inc
Jennifer Giottonini Cayer
Chief Business Officer – Pulmocide
Jackie Hernandez, CPA
Founder – Hernandez & Co. Consulting
Nancy A. Hong, PhD
Managing Director – RiverVest Venture Partners
Zachary Hornby
President & CEO – Boundless Bio, Inc.
Beth Hougen
Chief Financial Officer – Ionis Pharmaceuticals
Fleming Jones
Managing Director – FlemingMartin Executive Search
David Kabakoff
Executive Partner Private Equity – SOFINNOVA InvestmentsKim Kamdar
Partner – Domain Associates
Craig Knox
Senior Vice President – Hughes Marino
Neha Krishnamohan
CFO & EVP, Corporate Development – Kinnate Biopharma Inc.
Cathy Lee
EVP, General Counsel and Corporate Secretary – Metacrine
Hugh Leslie
Principal, Life Science & Technology Practice Lead – Marsh McLennan Agency
Alyssa Levin
Chief Financial Officer & Business Officer – Nkarta
Stanley Lewis M.D., M.P.H.
Founder and CEO – A288 Therapeutics
Erik Lundh
Co-Founder and Managing Partner – Park Square Executive Search
James Mackay, Ph.D.
President & CEO – Aristea Therapeutics
Mason Matthies
Managing Director – Donnelley Financial Solutions
Damien McDevitt, PhD
President & CEO – Aspen Neuroscience, Inc
Alana McNulty
Director – Janux Therapeutics
Shelly Meeusen
Chief Science Officer – Velia
Scott Moorefield
COO/CBO – Alterome Therapeutics
Bob More
Alta Partners
Bob More
Alta Partners
Jeff Morton
Partner & Leader of Life Sciences Sector Group – Procopio
Eric Murphy, Ph.D
Co-Founder, CEO & CSO – Alterome Therapeutics
Joe Panetta
President & CEO – Biocom California
Joseph Payne
Founder, President & CEO – Arcturus Therapeutics
Bill Rastetter
Chairman – FateChairman, Fate
Chairman, Neurocrine
Chairman, Daré
Vickie Reed
Board Member and Audit Chair; Chief Accounting Officer (retired)
Mirati Therapeutics (retired)
Vickie Reed
Board Member and Audit Chair; Chief Accounting Officer (retired) – Mirati Therapeutics (retired)
Mark Rothera
President & CEO – Viracta Therapeutics
Daniel Ryan
Co-Chief Investment Officer & Regional Market DirectorSan Diego Alexandria Real Estate Equities
San Diego Alexandria Real Estate Equities
Daniel Ryan
Co-Chief Investment Officer & Regional Market DirectorSan Diego Alexandria Real Estate Equities – San Diego Alexandria Real Estate Equities
Jean-Louis Saillot
Chief Development Officer – Inmagene BiopharmaceuticalsJosh Schimmer
Managing Director, Biotechnology Equity Research – Cantor Fitzgerald
Dan Schroeder
Managing Director – First Republic Bank, San Diego
Linda Sierra
SVP, Business Development – Bench International
Jodi Smith-Ungrodt
Partner – EY
Bruce Steel
Chief Executive Officer – Equillium
Laurie Stelzer
Chief Financial Officer – Mirati Therapeutics
Jason Stewart
Founder & CEO – Blake & Michaels
Peter Stolba
Vice President, Business Operations and Supply Chain – TriLink BioTechnologies
America Thompson
Vice President, Finance & Accounting – Kate Therapeutics
Ashley Van Zeeland, PhD, MBA
Vice President, Corporate & Business Development – Illumina
Christian Waage
Executive Vice President – Gossamer Bio
Lina Waage
Dr. Nancy Whiting
Chief Executive Officer – Recludix Pharma
Mark Wiggins
Chief Business Officer – Vaxcyte
Troy Wilson
President & CEO – Kura Oncology
Holly Winter
Senior Vice President Human Resources – Locanabio, Inc.
Ian Wisenberg
Chief Executive Officer – BioCina
Thomas Woiwode, PhD
Managing Director – Versant Ventures